🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Popularity Via Social Media

Retatrutide, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Followers are urged to contact these profiles directly for supplier links, while also receiving promotional offers.

Active Trade on Social Networks

Separately, a robust market exists on messaging services, where communities with thousands of members share comparison photos, injection guides and assertions of rapid UK delivery. Sellers market the substance there before redirecting buyers to WhatsApp for purchases.

Learning About Retatrutide

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The treatment affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could assist individuals reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Healthcare Experts Voice Worries

However, doctors and chemists have cautions that the sale of what is still an unlicensed medication in the United Kingdom is worrisome and could result in users administering products of unknown origin.

Several professionals said the popularity for the experimental drug could be linked to the rising price of approved weight loss treatments such as Mounjaro.

Legal Status and Enforcement

Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some content creators try to circumvent the rules by referring to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but promotion and supply can still violate medicines, marketing, and consumer regulations, risking penalties, prosecution or prison.

Service Response and Material Elimination

According to TikTok, the service has removed violative content and banned related hashtags and query recommendations. The company said it was committed to keeping the service secure and allocating resources in strengthening compliance measures.

Online Trading Operations

Research also found communities with up to nine thousand members marketing retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” instantly brings up channels with numerous of members, populated with images of weight loss, positive reviews and detailed instructions for mixing or injecting at residence.

Within minutes of joining one group, a vendor posted contact information, where the majority of purchases take place. The seller provided an instruction manual and promised shipping within two days. When questioned whether the substance was genuine, one vendor said: “You can’t be sure.” Another shared a image of a supposed testing documentation. None inquired about weight, health issues or past usage.

Product Information and Costs

Inside these communities, messages show dark colored packages with postal service stickers, claiming to include fresh supplies. One communication read: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, prepared at residence with purified liquid, or pre-filled pens typically priced at £160 for 20 milligrams. When questioned how long a pen should be used, vendors give contradictory answers varying between a few weeks to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service said it regularly monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“People are administering materials they can’t verify. Although the research behind this drug is sound, these digital versions may not include what they claim,” stated Jason Murphy, the director of pharmacy at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for approved weight-loss medications such as Mounjaro. “With prices increasing, patients are using online platforms. But fake treatments are highly dangerous. You cannot know what’s inside or whether the environment they were produced in was clean,” she said.

Her staff has previously seen patients injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated the substance was in third stage research studies and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a Lilly investigational product not yet approved … may subject patients to potentially serious medical dangers”.